Physician profile
Nerissa S Bauer
NPI 1851313068
$9,901.27
in general payments reported to CMS, 2019-2025
16 companies · $397 in 2025
The $397 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $65.90 · 2021: $152 · 2022: $317 · 2023: $253 · 2024: $8,368 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,365 · Travel and Lodging: $1,941 · Food and Beverage: $1,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,365.00 |
| Travel and Lodging | $1,940.96 |
| Food and Beverage | $1,711.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $8,440.43 | 2019-2024 | Jornay Pm |
| Corium, LLC | $488.66 | 2021-2025 | Azstarys, Azstarys |
| Supernus Pharmaceuticals, INC. | $341.20 | 2021-2025 | Qelbree, Qelbree |
| Neos Therapeutics, Lp | $138.14 | 2019-2025 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Tris Pharma INC | $103.29 | 2023-2025 | Dyanavel Xr, Onyda Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $69.30 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $66.72 | 2025 | Jornay Pm |
| Bausch Health US, LLC | $49.39 | 2019-2021 | |
| Lundbeck LLC | $44.63 | 2019-2020 | |
| Adlon Therapeutics L.P. | $35.90 | 2021 | |
| Vertical Pharmaceuticals, LLC | $35.64 | 2019-2025 | Relexxii |
| Vanda Pharmaceuticals INC. | $26.86 | 2021 | |
| Eisai INC. | $18.00 | 2022 | |
| Noven Therapeutics, LLC | $17.07 | 2024 | Xelstrym |
| Janssen Pharmaceuticals, INC | $14.56 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nerissa Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.